Adaptimmune Therapeutics plc (ADAP)
Share Price Chart
Loading data...
Performance
The chart shows the growth of $10,000 invested in Adaptimmune Therapeutics plc in Oct 2022 and compares it to the S&P 500 index or another benchmark. It would be worth nearly $681 for a total return of roughly -93.19%. All prices are adjusted for splits and dividends.
Compare to other instruments
Popular comparisons: ADAP vs. SCHD
Return
Adaptimmune Therapeutics plc had a return of -25.34% year-to-date (YTD) and -50.00% in the last 12 months. Over the past 10 years, Adaptimmune Therapeutics plc had an annualized return of -28.95%, while the S&P 500 had an annualized return of 8.51%, indicating that Adaptimmune Therapeutics plc did not perform as well as the benchmark.
Period | Return | Benchmark |
---|---|---|
1 month | -36.26% | -3.13% |
Year-To-Date | -25.34% | 2.92% |
6 months | -28.76% | 2.02% |
1 year | -50.00% | -11.46% |
5 years (annualized) | -36.31% | 7.79% |
10 years (annualized) | -28.95% | 8.51% |
Monthly Returns Heatmap
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 28.08% | -5.35% | ||||||||||
2022 | -45.71% | 32.09% | 52.82% | -32.72% |
Dividend History
Adaptimmune Therapeutics plc doesn't pay dividends
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way.
Worst Drawdowns
The table below shows the maximum drawdowns of the Adaptimmune Therapeutics plc. A maximum drawdown is an indicator of risk. It shows a reduction in portfolio value from its maximum due to a series of losing trades.
The maximum drawdown since January 2010 for the Adaptimmune Therapeutics plc is 96.57%, recorded on Nov 15, 2019. The portfolio has not recovered from it yet.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
---|---|---|---|---|---|---|
-96.57% | Jun 17, 2015 | 1114 | Nov 15, 2019 | — | — | — |
-14.05% | May 8, 2015 | 17 | Jun 2, 2015 | 7 | Jun 11, 2015 | 24 |
Volatility Chart
Current Adaptimmune Therapeutics plc volatility is 66.59%. The chart below shows the rolling 10-day volatility. Volatility is a statistical measure showing how big price swings are in either direction. The higher asset volatility, the riskier it is, because the price movements are less predictable.